Dec 14 2018 This Week in Cardiology
Carotid stents more stemcell retractions AHA statement on statin safety flu vaccine rules medication errors veterans care and wasteful NIH research on golfing are discussed in this weeks podcast....
View ArticleAdherence and Intensity of LipidLowering Tx Influence CV Risk
MONDAY Dec. 17 2018 Adherent patients receiving highintensity statin andor ezetimibe therapy have the lowest cardiovascular risk according to a study published online Dec. 7 in JAMA Network...
View ArticleAdherence and Intensity of LipidLowering Therapy Influences CV Risk
MONDAY Dec. 17 2018 Adherent patients receiving highintensity statin andor ezetimibe therapy have the lowest cardiovascular risk according to a study published online Dec. 7 in JAMA Network...
View ArticleResearchers discover that commonly prescribed cholesterollowering statin...
Researchers discover that commonly prescribed cholesterollowering statin drugs impact on a biochemical pathway that leads to reduced amounts of beneficial BAT in adults httpow.lyC89330n5UsP
View ArticlePrice of Alirocumab Would Have to Be Cut to Be CostEffective
WEDNESDAY Jan. 2 2019 For patients with a recent acute coronary syndrome receiving a statin the price of alirocumab would have to be reduced to be costeffective according to a study published online...
View ArticleStudy Finds Drops in ContraindicatedStatin Use in HIVInfected Adults on ART
Contraindicated statin use declined between 2007 and 2015 in HIVinfected adults treated with antiretroviral therapy ART while overall use remains suboptimal researchers report. Reuters Health Information
View ArticleThe REDUCEIT trial Icosapent ethyl reduces ischemic event risk in patients...
1. After a median followup of 4.9 years patients with elevated triglyceride levels despite statin use treated with icosapent ethyl had a lower risk of cardiovascular adverse events compared to patients...
View ArticleArrowhead Pharmaceuticals Begins Dosing in Phase 1 Study of AROANG3 for...
Arrowhead Pharmaceuticals Inc. NASDAQ ARWR today announced that it has dosed the first subjects in a Phase 1 clinical study of AROANG3 an RNAibased investigational medicine targeting angiopoietin like...
View ArticleStatin adherence remains low in postMI highrisk patients
A study published Jan. 8 in the Journal of the American Heart AssociationÂsuggests patient adherence to statin therapy in the U.S. remains low particularly among younger individuals minorities and...
View ArticleKowa Pharmaceuticals America Inc. Announces Appeals Court Decision Upholding...
Kowa Pharmaceuticals America Inc. announced today that the U.S. Court of Appeals for the Federal Circuit has affirmed the decision by the U.S. District Court for the Southern District of New York...
View ArticleStatins Tied to Lower Risk for Diabetic Retinopathy
Statin therapy is associated with decreased risk for retinopathy in those with type 2 diabetes and dyslipidemia according to a retrospective study in JAMA Ophthalmology...
View ArticleVisualAbstract Cardiovascular Risk Reduction with Icosapent Ethyl for...
1. After a median followup of 4.9 years patients with elevated triglyceride levels despite statin use treated with icosapent ethyl had a lower risk of cardiovascular adverse events compared to patients...
View ArticleGuidelinerecommended statin treatment hampered by clinician beliefs
Clinicians personal beliefs about the safety and efficacy of statins play a larger role in their likelihood of prescribing the medications than their knowledge of cholesterol guidelines according to a...
View ArticleStatin Therapy Reduces Risk for Diabetic Retinopathy in T2DM
FRIDAY Jan. 11 2019 For Taiwanese patients with type 2 diabetes and dyslipidemia statin therapy is associated with a reduced risk for diabetic retinopathy according to a study published online Jan. 10...
View ArticleIncreased intensity plus adherence maximises statin benefits
High adherence to intensive lipidlowering therapy provides the greatest risk reduction for cardiovascular events a study in JAMA Network Open has shown.
View ArticleLuye Selects AstraZeneca to Market its AntiCholesterol Drug in China
Luye Pharma outlicensed mainland China marketing rights for its anticholesterol Xuezhikang capsules to AstraZeneca China. Xuezhikang is a fermented form of red yeast rice that is similar to a statin....
View ArticleStatins Underused by Adults With Chronic Kidney Disease
Although a 2013 guideline recommended statin use to more than 65 of adults with CKD only about 36 of adults with CKD were taking a statin in 20112014.
View ArticleElevated Lipoproteina Levels Are Associated with Increased Cardiovascular...
irrespective of whether patients are on statin therapy.
View ArticlePCSK9Inhibitors High Price to Pay for Improved Cardiac Outcomes
Adding a proprotein convertase subtilisinkexin 9 drug to a statin is not costeffective after myocardial infarction.
View ArticleStatin prescriptions remained low after claiming larger role in guidelines
Although the 2013 American College of Cardiology and American Heart Association cholesterol guidelines expanded indications for statin use in heart patients few primary care providers PCPs are...
View Article